Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design
- PMID: 19925414
- DOI: 10.2174/138161209789271852
Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design
Abstract
Matrix metalloproteinases are involved in many biological processes and in a large set of diseases. In the last twenty years the genetics, functions, and the structural features of this family of proteolytic enzymes have been investigated and a large number of synthetic inhibitors designed and tested. A better knowledge of the dynamical features of these proteins can be relevant not only to reveal new biological activities but also to design more specific and selective inhibitors. Here, we report the common and the distinct structural features of these proteins, the most recent published information on protein dynamics in matrix metalloproteinases and the recent results on the catalytic mechanism. The implications of the observed intra- and interdomain flexibility in matrix metalloproteinases for drug design have been analyzed and discussed.
Similar articles
-
Structural studies of matrix metalloproteinases.J Mol Med (Berl). 2000;78(5):261-8. doi: 10.1007/s001090000113. J Mol Med (Berl). 2000. PMID: 10954198 Review.
-
Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.Mol Biotechnol. 2003 Nov;25(3):241-66. doi: 10.1385/MB:25:3:241. Mol Biotechnol. 2003. PMID: 14668538 Review.
-
Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.Int J Exp Pathol. 2010 Aug;91(4):303-13. doi: 10.1111/j.1365-2613.2010.00736.x. Int J Exp Pathol. 2010. PMID: 20666850 Free PMC article.
-
The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.Curr Med Chem. 2004 Nov;11(22):2911-77. doi: 10.2174/0929867043364018. Curr Med Chem. 2004. PMID: 15544483 Review.
-
Quest for selectivity in inhibition of matrix metalloproteinases.Curr Top Med Chem. 2004;4(12):1227-38. doi: 10.2174/1568026043387854. Curr Top Med Chem. 2004. PMID: 15320723 Review.
Cited by
-
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):201-12. doi: 10.1007/s10911-010-9177-x. Epub 2010 May 5. J Mammary Gland Biol Neoplasia. 2010. PMID: 20440544 Free PMC article. Review.
-
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.J Cell Biochem. 2017 Nov;118(11):3531-3548. doi: 10.1002/jcb.26185. Epub 2017 Jul 17. J Cell Biochem. 2017. PMID: 28585723 Free PMC article. Review.
-
Matrix metalloproteinases as breast cancer drivers and therapeutic targets.Front Biosci (Landmark Ed). 2015 Jun 1;20(7):1144-63. doi: 10.2741/4364. Front Biosci (Landmark Ed). 2015. PMID: 25961550 Free PMC article. Review.
-
Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases.ACS Pharmacol Transl Sci. 2022 Nov 28;5(12):1228-1253. doi: 10.1021/acsptsci.2c00183. eCollection 2022 Dec 9. ACS Pharmacol Transl Sci. 2022. PMID: 36524013 Free PMC article. Review.
-
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.Cells. 2020 May 25;9(5):1313. doi: 10.3390/cells9051313. Cells. 2020. PMID: 32466129 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources